Live Breaking News & Updates on Krishnamoorthy sundaresan

Stay updated with breaking news from Krishnamoorthy sundaresan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pfizer Receives Authorization from Health Authority for the First Dual Indication Vaccine Approved in Hong Kong

Pfizer Receives Authorization from Health Authority for the First Dual Indication Vaccine Approved in Hong Kong
asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , Macau , Krishnamoorthy-sundaresan , Pfizer , Department-of-health , Hong-kong-department-of-health , Prnewswire-pfizer-inc , Pfizer-inc , World-health-organization , Centers-for-disease , Fight-against-respiratory-syncytial-virus , Older-adults-aged

Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management

HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant in Hong Kong, the first market in Asia, a calcitonin gene-related

Thailand , Macau , United-states , United-kingdom , Hong-kong , Krishnamoorthy-sundaresan , Brain-research-united-kingdom , Youtube , Exchange-commission , Pfizer , International-headache-society , Pfizer-corporation-hong-kong